Etoposide, dexamethasone, and pegaspargase with sandwiched radiotherapy in early-stage natural killer/T-cell lymphoma: A randomized phase III study

Etoposide, dexamethasone, and pegaspargase with sandwiched radiotherapy in early-stage natural killer/T-cell lymphoma: A randomized phase III study

Methotrexate, etoposide, dexamethasone, and pegaspargase (MESA) with sandwiched radiotherapy is known to be effective for early-stage extranodal natural killer/T-cell lymphoma, nasal type (NKTCL). We explored the efficacy and safety of reduced-intensity, non-intravenous etoposide, dexamethasone, and...

Full description

Bibliographic Details
Main Authors: Huijuan Zhong, Shu Cheng, Xi Zhang, Bing Xu, Jiayi Chen, Xufeng Jiang, Jie Xiong, Yu Hu, Guohui Cui, Juying Wei, Wenbin Qian, Xiaobing Huang, Ming Hou, Feng Yan, Xin Wang, Yongping Song, Jianda Hu, Yuanhua Liu, Xuejun Ma, Fei Li, Chongyang Wu, Junmin Chen, Li Yu, Ou Bai, Jingyan Xu, Zunmin Zhu, Li Liu, Xin Zhou, Li Huang, Yin Tong, Ting Niu, Depei Wu, Hao Zhang, Chaofu Wang, Binshen Ouyang, Hongmei Yi, Qi Song, Gang Cai, Biao Li, Jia Liu, Zhifeng Li, Rong Xiao, Luqun Wang, Yujie Jiang, Yanyan Liu, Xiaoyun Zheng, Pengpeng Xu, Hengye Huang, Li Wang, Saijuan Chen, Weili Zhao
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:The Innovation
Online Access:http://www.sciencedirect.com/science/article/pii/S2666675823000541

Internet

http://www.sciencedirect.com/science/article/pii/S2666675823000541

Similar Items